Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.93 USD | -1.08% | -5.45% | -16.35% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.35% | 220M | |
+27.72% | 426B | |
+29.44% | 276B | |
+2.68% | 135B | |
+6.33% | 92.01B | |
+25.57% | 89.16B | |
+65.00% | 58.86B | |
+9.80% | 45.03B | |
+19.19% | 34.77B | |
-12.20% | 31.93B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Piper Sandler Adjusts Price Target on OptimizeRx to $16 From $29, Maintains Neutral Rating